Home > SWOT Analysis > Genzyme (GENZ) SWOT Analysis



Genzyme (GENZ) SWOT Analysis Profile

Genzyme Corporation is a global pharmaceutical and biotechnology company which develops and distributes products that treat patients suffering from renal diseases; Gaucher disease; Fabry disease; thyroid cancer; Pompe disease; osteoarthritis; and mucopolysaccharidosis I. The company also creates and distributes antibodies that suppresses immune cells responsible for acute organ rejection in transplant and graft patients, and provides genetic testing services such as reproductive testing services, diagnostic services, and genetic counseling. (read full profile)

Additional Information

What is a SWOT Analysis? It is a way of evaluating the strengths, weaknesses, opportunities, and threats that affect something. See WikiWealth's SWOT tutorial for help. Remember, vote up the most important comments. Check out WikiWealth's entire database of free SWOT reports or use our SWOT analysis generator to create your own SWOT template.

Receive News & Ratings Via Email

Free Email Newsletter

SWOT Conclusion

Strengths + Opportunities = 1

Threats + Weaknesses = 3

… A history of overcoming weaknesses makes it difficult for other firms to exploit their difficulties. The ability to capitalize on opportunities get rewarded with higher profits and lower costs.